Tamoxilon 20 mg Tablet

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Tamoxilon 20 mg Tablet contains tamoxifen, a selective estrogen receptor modulator. Its labelling describes it for the treatment of breast cancer, for reducing breast cancer risk in pre- and postmenopausal women at high risk, and for the treatment of infertility, as well as other conditions as the doctor sees fit. It is described as altering the production of certain hormones responsible for the growth and spread of breast cancer, slowing the growth and multiplication of cancer cells.

Active ingredient
Tamoxifen (as citrate)
Strength
20 mg
Dosage form
Oral tablet
Therapeutic class
Selective estrogen receptor modulator (SERM)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of breast cancer
  • Described for reducing breast cancer risk in pre- and postmenopausal women at high risk
  • Described for the treatment of infertility, and other conditions as the doctor sees fit
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Taken before or after a meal, at the same time every day for best results
  • The doctor’s instructions on how to take the tablet and the interval should be followed
  • Effective birth control should be used at all times during the medication

Described Side Effects

Commonly described side effects include:

  • Nausea
  • Other temporary common effects as described in the labelling

The doctor should be contacted immediately if side effects persist.

Precautions

  • A complete medical history should be shared with the doctor
  • The doctor should be informed specifically about ongoing infertility treatment or any history of a blood clot disorder, and about pregnancy or breastfeeding
  • Tests to check liver function and calcium levels may be carried out
  • Effective birth control should be used at all times during the medication

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains tamoxifen and is used for the treatment of breast cancer, for reducing breast cancer risk in high-risk women, and for infertility. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as taken before or after a meal at the same time every day, following the doctor’s instructions on dose and interval, with effective birth control used throughout.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services